PPA
CTIC

Parametric Portfolio Associates’s CTI BioPharma Corp. (DE) Common Stock CTIC Stock Holding History

Parametric Portfolio Associates’s Portfolio CTIC Stock Details CTIC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q1 		$1.1M Buy
+236,065
New +$704K ﹤0.01% 2735
2019
Q1 		– Sell
-44,554
Closed -$33K – 4041
2018
Q4 		$33K Buy
44,554
+729
+2% +$1.2K ﹤0.01% 3872
2018
Q3 		$95K Buy
+43,825
New +$109K ﹤0.01% 3854
2015
Q3 		– Sell
-2,031
Closed -$40K – 3539
2015
Q2 		$40K Buy
2,031
+137
+7% +$2.64K ﹤0.01% 3933
2015
Q1 		$34K Buy
1,894
+611
+48% +$13.8K ﹤0.01% 3920
2014
Q4 		$30K Sell
1,283
-1,267
-50% -$29.3K ﹤0.01% 3965
2014
Q3 		$62K Buy
+2,550
New +$66.3K ﹤0.01% 3763
2014
Q2 		– Sell
-2,233
Closed -$76K – 3926
2014
Q1 		$76K Buy
2,233
+17
+0.8% +$581 ﹤0.01% 3760
2013
Q4 		$42K Buy
+2,216
New +$40.3K ﹤0.01% 3792

Other funds holding CTIC

NMC
NEA Management Company Timonium, Maryland $1.59B AUM 234.06% 1-Year Est. Return
BI
BVF Inc San Francisco, California $3.91B AUM 304.52% 1-Year Est. Return
LPC
Lion Point Capital New York $20.9M AUM 195.52% 1-Year Est. Return
SCM
Stonepine Capital Management Bend, Oregon $177M AUM 91.13% 1-Year Est. Return
BL
Bleichroeder LP New York $559M AUM 83.7% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
SCM
Silverarc Capital Management Boston, Massachusetts $962M AUM 524.64% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return
SI
Sofinnova Investments Menlo Park, California $1.93B AUM 134.74% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return

Parametric Portfolio Associates's CTIC Position: Q1 2022 in Review

Parametric Portfolio Associates opened a new position in CTI BioPharma Corp. (DE) Common Stock (CTIC) in Q1 2022: 236,065 shares worth $1.1M. The stake represents ﹤0.01% of the portfolio and ranks #2735 among its holdings. This is a return to the name: Parametric Portfolio Associates previously reported a position in CTIC as recently as Q4 2018.

Parametric Portfolio Associates first reported a position in CTIC in Q4 2013 and has held it in 9 quarters since. 92 funds tracked by Wall St. Rank hold CTIC as of Q1 2022.

  • Parametric Portfolio Associates held 236,065 shares of CTI BioPharma Corp. (DE) Common Stock worth $1.1M as of Q1 2022.
  • CTI BioPharma Corp. (DE) Common Stock was a new Parametric Portfolio Associates position in Q1 2022.
  • CTI BioPharma Corp. (DE) Common Stock made up ﹤0.01% of Parametric Portfolio Associates's portfolio in Q1 2022, its #2735 holding.
  • Parametric Portfolio Associates first reported a position in CTI BioPharma Corp. (DE) Common Stock in Q4 2013 and has held it in 9 quarters since.
  • 92 funds tracked by Wall St. Rank held CTI BioPharma Corp. (DE) Common Stock as of Q1 2022.

Based on Parametric Portfolio Associates's 13F filing for Q1 2022, filed 16 May 2022.